Products for Research Use Only
RegisterLogin

Bepranemab

CAT: 0804-HY-P99471-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99471-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Bepranemab (UCB 0107) is a humanized, full-length IgG4 monoclonal antibody. Bepranemab targets the central portion of tau, specifically amino acids 235 to 246. Bepranemab can be used for Alzheimer’s disease (AD) research[1][2].
CAS Number
2244960-75-4
Product Name Alternative
UCB 0107
UNSPSC
12352203
Target
Tau Protein
Type
Inhibitory Antibodies
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bepranemab.html
Purity
99.90
Solubility
10 mM in DMSO
Smiles
[Bepranemab]
Molecular Weight
(145.52 kDa)
References & Citations
[1]Matthew E Barton, et al. Design of a patient- and investigator-blind, randomized, placebo-controlled study to evaluate efficacy, safety, and tolerability of bepranemab, UCB0107, in prodromal to mild Alzheimer’s disease: The TOGETHER Study, AH0003. Alzheimer's & Dementia. 31 December 2021.|[2]Neațu M, et al. Monoclonal Antibody Therapy in Alzheimer's Disease. Pharmaceutics. 2023 Dec 29;16 (1) :60.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
abx831733-01Bepranemab
GTR18337845-01Bepranemab Antibody
047947Tau (bepranemab) discontinued
MBS1563486-01Research Grade Bepranemab
E55B0525Bepranemab (Reference antibody)
C00783-01Bepranemab (Anti-Tau)
F1546-.1Anti-Tau Antibody (Bepranemab)
A137957Bepranemab Biosimilar (Monoclonal, IgG4)
ICH5391-25mgBepranemab Biosimilar - Research Grade
GTR18697653-01Bepranemab Human Monoclonal Antibody

Popular Products